Sun, DRL, Mylan, Aurobindo, Zydus, MSN, Prinston, Intas, HEC, Solco, Huahai and Invagen (Total 12 Generic company) are plaintiff in patent litigation of TRADJENTA Tablet 5MG (Active: LINAGLIPTIN) having blockbuster sale with $356.8 Million in year 2015.TRADJENTA tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Explore more about Linagliptin
No comments:
Post a Comment